Skip to main content

Table 1 Clinical and demographic variables at ICU admission

From: Eosinophil count at intensive care unit admission was not predictor of hospital mortality: results of a case control study

Variable Total Survivors Non-survivors P value
Patients 185 (100.0) 99 (53.5) 86 (46.5)  
Age, years 47 (18.2) 43 (17.4) 51 (18.3) 0.003
Men 128 (69.2) 74 (74.7) 54 (62.8) 0.079
APACHE II, score 16 (1–37) 12 (1–30) 21 (9–37) <0.001
SOFA, score 6 (0–20) 5 (0–14) 9 (2–20) <0.001
Predicted mortality, % 25 (4–85) 15 (4–75) 40 (9–85) <0.001
Comorbidities     
 DM2 58 (31.4) 23 (23.2) 35 (40.7) 0.011
 Ischemic cardiopathy 24 (13.0) 12 (12.1) 12 (14.0) 0.711
 Chronic nephropathy 23 (12.4) 5 (5.1) 18 (20.9) 0.001
 Chronic liver disease 7 (3.8) 2 (2.0) 5 (5.8) 0.265
 Chronic pneumopathy 7 (3.8) 4 (4.0) 3 (3.5) 1.000
 Blood neoplasia 1 (0.5) 1 (1.0) 0 (0.0) 1.000
 Solid neoplasia 15 (8.1) 4 (4.4) 11 (12.8) 0.030
 HIV infection 5 (2.7) 1 (1.0) 4 (4.7) 0.285
ICU admission diagnosis     
 Medical 87 (47.0) 37 (37.4) 50 (58.1) 0.005
 Surgical, urgent 40 (21.6) 19 (19.2) 21 (24.4) 0.389
 Surgical, elective 25 (13.5) 21 (21.2) 4 (4.7) 0.001
 Trauma 33 (17.8) 22 (22.2) 11 (12.8) 0.095
 ICU admission eosinophils count, K/μL 0.013 (0.0–0.578) 0.014 (0.0–0.363) 0.010 (0.0–0.578) 0.355
 Hospital stay, days 14 (2–96) 18 (3–96) 11.5 (2–56) 0.007
 ICU stay, days 6 (1–46) 5 (1–28) 7.5 (1–46) 0.004
  1. Data are shown as number and percentage, mean and standard deviation or median and interquartile range as needed
  2. ICU intensive care unit, APACHE II acute physiology and chronic health evaluation II, SOFA sequential organ failure assessment score, DM2 type 2 diabetes mellitus, HIV human immunodeficiency virus